Bolt Biotherapeutics, Inc.
SEC CIK 1641281 · BOLT · last insider filing 2026-06-11
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Laporte Kathleen | Director | filed 2021 - 2026 |
| Onetto Nicole | Director | filed 2021 - 2026 |
| O'Callaghan Brian | Director | filed 2021 - 2026 |
| Dupont Jakob | Director | filed 2024 - 2026 |
| Berner Laura | Director | filed 2022 - 2026 |
| Quinn William P. | Director · President, CEO and CFO | filed 2021 - 2026 |
| Healy James | Director | filed 2021 - 2024 |
| Shah Mahendra | Director | filed 2021 - 2024 |
| Lee Frank D. | Director | filed 2021 - 2024 |
| Schatzman Randall C | Director · Chief Executive Officer | filed 2021 - 2024 |
| Engleman Edgar | Director | filed 2021 - 2023 |
| Miller Richard A MD | Director | filed 2021 - 2023 |
| Khanna Ashish Siri Ram | Director | filed 2021 - 2021 |
| Moldt Peter | Director | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Yonehiro Grant | Chief Operating Officer | filed 2021 - 2026 |
| Nemec Sarah | VP, Finance and PAO | filed 2024 - 2026 |
| Perez Edith A. | Chief Medical Officer | filed 2021 - 2024 |
| Dornan David | Chief Scientific Officer | filed 2021 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.